Healthcare - Page 1 | TalkMarkets
All Posts > Content under Healthcare
1 to 16 of 3922 Posts
1 2 3 ... 246
E The Good, The Bad And The Ugly: Gilead Sciences
Video By: Dr. Joseph Belmonte
Friday, April 28, 2017 4:08 PM EDT
Gilead is not your father's growth stock anymore nor should it be yours either.
In this video: GILD
Watch
IDEXX Laboratories Boosts Outlook Amid Strong Q1 Results
Article By: Lorimer Wilson
Friday, April 28, 2017 10:39 AM EDT
IDEXX Laboratories, Inc. early Friday posted much better than expected first quarter earnings results and lifted its full-year forecast, sending its shares significantly higher in morning trading.
In this article: IDXX
Read
Bristol-Myers Squibb: Strong Earnings Could Warrant Higher Dividend Growth Ahead
Article By: SureDividend
Friday, April 28, 2017 10:01 AM EDT
Bristol-Myers has a low payout ratio, a high level of profitability, and a strong balance sheet. These are the ingredients that should allow the company to raise its future dividend increases, possibly in the mid-single digit range.
In this article: BMY
Read
A Deluge And An Eclipse
Article By: Marvin R Clark
Thursday, April 27, 2017 11:33 PM EDT
Today brought a deluge of earnings.Google parent Alphabet posted a 29 percent rise in quarterly profit, driven by a surge in advertising on mobiles and its popular YouTube video service.
In this article: BMY, DPZ, F, KKR, LNKD, LUV, UPS, AMZN, GOOG, INTC, MSFT, SBUX, AAL, ABBV, GOOGL, CCV
Read
The Short-Term Trend
Article By: Douglas Gammons
Thursday, April 27, 2017 5:25 PM EDT
The market has stalled a bit after the big breakout. This is starting to look like a rally up to the top of the range. Then again, we are in the middle of earnings and there is tons of news everyday.
In this article: VGK, SOXX, MU, SPX, PPH
Read
AbbVie’s Humira Revenue Up 15% (Despite Patent Cliff Fears)
Article By: SureDividend
Thursday, April 27, 2017 3:54 PM EDT
Will discuss why AbbVie’s earnings report was better than anticipated, and what investors can expect from this stock moving forward.
In this article: ABBV Also: ABT
Read
Today's Stock Watch List
Article By: Ryan Mallory
Thursday, April 27, 2017 11:52 AM EDT
Today's stock watch list includes NSC, GRUB and ABT.
In this article: NSC, GRUB, ABT
Read
Bristol-Myers Squibb Co. Ups Forecast As Q1 Earnings Beat The Street
Article By: Lorimer Wilson
Thursday, April 27, 2017 11:27 AM EDT
Bristol-Myers Squibb Co. early Thursday posted much better than expected first quarter earnings results and lifted its full-year outlook, as sales of several of its new drugs begin to skyrocket.
In this article: BMY
Read
Celgene Beats On Q1 Earnings, Misses On Sales
Article By: Zacks Investment Research
Thursday, April 27, 2017 10:02 AM EDT
Celgene beat on first-quarter 2017 earnings. The company reported EPS of $1.53 (including share-based compensation expense and tax adjustments) while our consensus called for EPS of $1.47.
In this article: CELG
Read
E China Yields To Trump; Putin Pushes
Article By: Vivian Lewis
Thursday, April 27, 2017 10:00 AM EDT
There are four company quarterly reports to deal with plus other important news.
In this article: BCE, CRH, GSK, SAN, BNS, NVS, RHHBY, TEVA, BVNRY, GLPG, GNCGY, MXCHF, VOD
Read
The Most Hated Bull Market In History: Update
Article By: Rambus Chartology
Thursday, April 27, 2017 10:00 AM EDT
The US stock markets have been in a bull market since 2009 by any trading discipline. It has climbed the proverbial wall of worry which is needed to create such a dynamic bull market.
In this article: SOX, BTK, XLV, XHB, DAX, BKX, TRAN, SPX
Read
Premarket Biotech Digest – ANTM May Increase Premium, IPXL Receives FDA Approval, ZTS Receives EC Nod
Article By: KKD Healthcare Analytics
Thursday, April 27, 2017 7:20 AM EDT
Impax Laboratories announced receiving the FDA approval for its its generic version of cholesterol drug Vytorin. Anthem said that its premium may increase by 20 percent or more pursuant to the loss of federal subsidies supporting Obamacare plans.
In this article: AZN, DDD, ALNY, IPXL, MNOV, UTHR, ZTS, ANTM, FLKS
Read
Above The 40 – A Stretched S&P 500 Loses Bid For Overbought Status
Article By: Dr. Duru
Thursday, April 27, 2017 3:24 AM EDT
The S&P 500 fell just short of 2,400 before fading to a flat close. If buyers do not step back in quickly, the index will risk a full retreat to 50DMA support (where I will happily reload on S&P 500 longs).
In this article: UVXY, QQQ, NFLX, FXE, SPY, ESRX, X Also: VIX, ANTM, FXC
Read
Amgen Inc. Lifts Low End Of EPS Outlook Amid Mixed Q1 Earnings
Article By: Lorimer Wilson
Wednesday, April 26, 2017 5:42 PM EDT
Amgen, Inc. Wednesday posted mixed first quarter earnings and lifted the low end of its 2017 profit outlook, as it continues to struggle to produce meaningful revenue gains amid a harsh regulatory environment.
In this article: AMGN
Read
Most Active Stock Options For End Of Day - Wednesday, April 26
Article By: The Options Insider
Wednesday, April 26, 2017 4:48 PM EDT
The most active options for end of day Wednesday - BX, NSC, BAC, MRK and V.
In this article: BX, BAC, NSC, MRK, V
Read
Akebia Therapeutics, Inc. Shares Shoot Up On Announcement Of Collaboration With Otsuka
Article By: TickerTV
Wednesday, April 26, 2017 8:45 AM EDT
AKBA opened trading yesterday at $9.38 which was up from the previous day’s trading close of $9.31. Shares closed trading yesterday at $9.37 and spiked up after market to $12.25, equivalent to a 31% increase from the closing price.
In this article: AKBA
Read
1 to 16 of 3922 Posts
1 2 3 ... 246